A new policy framework is the only way to ensure that progress made for the 30 million people living with a rare disease in Europe is not left to luck or chance during the next decade. The eight Rare 2030 recommendations, the result of the two-year participative Foresight Study led by EURORDIS-Rare...
Latest News
A drug derived from the hydrangea root, used for centuries in traditional Chinese medicine, shows promise in treating autoimmune disorders, report researchers from the Program in Cellular and Molecular Medicine and the Immune Disease Institute at Children’s Hospital Boston (PCMM/IDI), along with the Harvard School of Dental Medicine. In the...
Auckland, New Zealand – A molecule created at the University of Auckland is one step closer to becoming a treatment for an extremely rare and severely debilitating neurological disorder called Phelan-McDermid syndrome. According to Neuren Pharmaceuticals, a biopharmaceutical company that is listed on the Australian Securities Exchange, children with the...
Nagoya, Japan – Researchers at Nagoya University in Japan and their collaborators have used a biomarker based on microbubbles to evaluate the success of near-infrared photoimmunotherapy (NIR-PIT) treatment. Using ultrasound to track the microbubbles, they were able to identify areas where cancer therapy had not been fully applied. Their findings...
The future treatment of Parkinson’s Disease has undergone tremendous development in recent years. Now, a breakthrough in research has emerged, delivering the strongest results for both side-effect-free and long-lasting treatment effects. Aarhus, Denmark – The results were just published in Nature Communications under the title “Enhanced production of mesencephalic...
Baton Rouge, Louisiana – A new partnership between a Pennington Biomedical physician-researcher at the Metamor Institute and an LSU School of Medicine oncologist has already saved women’s lives in southeast Louisiana. More than 60,000 women are diagnosed with endometrial cancer each year, a number that includes women much younger than...
In recent years, tumor immunotherapy has emerged as a highly promising and much-touted oncological approach. It is based on using humanized antibodies called immune checkpoint inhibitors (ICIs) to block the cellular pathways that inhibit the activity of T lymphocytes, a type of immune system cells that help protect the body...
Brighton, UK – New research by the University of Sussex could help to increase life expectancy and improve treatment for an aggressive brain cancer, which impacts thousands of people every year in the UK, and hundreds of thousands worldwide. In the study, published in the journal of Advanced Science, researchers have...
London, UK – Researchers have found that children of women with HIV infection have an increased risk of immune abnormalities following exposure to maternal HIV viraemia, immune dysfunction, and co-infections during pregnancy. The study, led by Dr Ceri Evans while at Queen Mary University of London, compared clinical outcomes between...
Larchmont, New York – A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) evaluated the use of tirzepatide in overweight/obese adults with type 1 diabetes. Click here to read the full article. Tirzepatide is approved for managing type 2 diabetes. It improves glucose control, facilitates weight loss, and...